Gyre Therapeutics Inc. (GYRE)
NASDAQ: GYRE
· Real-Time Price · USD
8.11
-0.11 (-1.34%)
At close: Aug 15, 2025, 3:59 PM
8.14
0.37%
After-hours: Aug 15, 2025, 04:04 PM EDT
Gyre Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
undefined.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | 1.58M | 2.7M | -99K | 2.86M | 4.54M | 9.94M | -52.19M | -1.58M | -2.47M | 260K | -40.45M | -4.88M | 51.63M | -14.54M | -20.33M | -25.24M | -19.93M | -22.44M |
Depreciation & Amortization | 641K | 535K | 471K | 425K | 238K | 425K | 308K | 63K | 1K | 3K | 10K | 40K | 67K | 113K | 115K | 85K | 45K | 45K |
Stock-Based Compensation | 906K | 507K | 567K | 237K | 16K | 11K | 7.28M | 98K | 89K | 177.28K | 257K | 224K | 346K | 515K | 683K | 713K | 983K | 1.03M |
Other Working Capital | n/a | -3.34M | 2.16M | -781K | -3.33M | -2.07M | 4.63M | -1.27M | -1.91M | -6.54M | 1.94M | 2.64M | -4M | 832K | -4K | -45K | 864K | -2.33M |
Other Non-Cash Items | -1.03M | -332K | -7K | 133K | -2.8M | -4.42M | 43.64M | 11.94M | -56K | -4.74M | 35.45M | 110K | -57.24M | 200K | -946K | -2M | 3.16M | 1.78M |
Deferred Income Tax | n/a | -191K | n/a | n/a | -97K | -313K | n/a | -1.21M | 56K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | n/a | -3.35M | -3.69M | -1.93M | -7.38M | -2.76M | 4.33M | -1.74M | -89K | -1.95M | 3.26M | -2.77M | -7.09M | 1.66M | 1.85M | 2.84M | -1.22M | -2.99M |
Operating Cash Flow | 2.09M | -129K | -2.76M | 1.73M | -5.49M | 2.88M | 3.36M | 7.58M | -2.47M | -6.22M | -1.48M | -7.28M | -12.29M | -12.05M | -17.68M | -21.6M | -20.12M | -24.36M |
Capital Expenditures | -256K | -122K | 65K | -693K | -1.46M | -231K | -2.38M | -2.43M | -1.84M | -3.17M | 2.58M | -1.93M | -2.58M | -634.17K | -347K | -492K | -347K | n/a |
Cash Acquisitions | n/a | n/a | n/a | -50K | n/a | 50K | 2.73M | 2.73M | 5M | 1M | 51K | n/a | 55.45M | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | -1.69M | 14.07M | -7.04M | -7.04M | n/a | n/a | -3.16M | n/a | -2.63M | n/a | -52.87M | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 5M | n/a | 2.5M | n/a | 55M | 2.5M | 2.87M | 7.53M | 11.05M | 27.58M |
Other Investing Acitivies | -2.79M | 2.09M | -383K | -15.72M | 218K | n/a | -1.13M | 696.7K | -205K | 2.58M | -2.45M | 594.42K | -55M | -5.62M | 2.87M | 7.53M | 11.05M | 27.58M |
Investing Cash Flow | -3.04M | 1.97M | -2M | -2.39M | -8.27M | -7.22M | -776.15K | 1M | 4.79M | 411K | 51K | -1.33M | 52.87M | 2.5M | 2.87M | 7.04M | 10.7M | 27.58M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -134.27K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -4K | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1.5M | -3.5M | -7.76M | -45.03M | -45.03M | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 22.35M | -121K | -367K | -50K | -119K | n/a | 1.38M | n/a | -131.34K | 136.26K | 45.15M | -45.03M | -121.56K | n/a | n/a | n/a | n/a | n/a |
Financial Cash Flow | 22.35M | 1.34M | 964K | 324K | 156K | 658K | 1.38M | -1.48M | -3.5M | -7.76M | 16K | -45.03M | -121.56K | 16K | n/a | 98K | -4K | 49.46M |
Net Cash Flow | 21.45M | 3.23M | -4.05M | -231K | -13.69M | -3.72M | 4.49M | 2.35M | -1.18M | -13.57M | -1.42M | -52.3M | 40.58M | -9.53M | -14.81M | -14.46M | -9.42M | 52.68M |
Free Cash Flow | 1.83M | -251K | -2.69M | 1.03M | -6.95M | 2.65M | 1.65M | -5.65M | -4.31M | -9.39M | 1.1M | -9.2M | -14.87M | -12.68M | -18.02M | -22.09M | -20.47M | -24.36M |